Prescription of selective serotonin reuptake inhibitors in Norway, 1990-2004;Forskrivning av selektive serotoninreopptakshemmere 1990-2004

Tidsskrift for den Norske Laegeforening

Volumn 125, Issue 18, 2005, Pages 2470-2473

  Bramness, Jørgen G ^a   Hausken, Anne Margrethe ^a   Sakshaug, Solveig ^a   Skurtveit, Svetlana ^a   Rønning, Marit ^a  

^a Nasjonalt Folkehelseinstitutt ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIDEPRESSANT AGENT;

AGE DISTRIBUTION; ARTICLE; CHILDHOOD DISEASE; DATA BASE; DEPRESSION; DRUG MARKETING; DRUG USE; GERIATRIC DISORDER; HUMAN; MASS MEDIUM; NORWAY; NORWEGIAN PRESCRIPTION DATABASE; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PUBLIC HEALTH; SEX RATIO; ADOLESCENT; ADULT; AGED; CHILD; DRUG UTILIZATION; FEMALE; MALE; MIDDLE AGED; STATISTICS;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHILD; DEPRESSION; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NORWAY; PRESCRIPTIONS, DRUG; SEROTONIN UPTAKE INHIBITORS;

EID: 26044435746     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Lingjærde O. Nyere antidepressiver - brukes de for mye eller for lite. Tidsskr Nor Lægeforen 1998; 118: 4493.
2. Tanum L. Deprimerte får for lite legemidler. Dagbladet 27.4.2002.
3. Holte A. Piller eller prat. Dagbladet 7.4.2001.
4. Ferguson J. SSRI antidepressant medications: adverse effects and tolerability. Prim Care Companion J Clin Psychiatry 2001; 3: 22-7.
5. Black K, Shea C, Dursun S et al. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatr Neurosci 2000; 25: 255-61.
6. Gibbons R, Hur K, Bhaumik D et al. The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 2005; 62: 165-72.
7. Nutt D. Death and dependence: current controversies over the selective serotonin reuptake inhibitors. J Psychopharmacol 2003; 17: 355-64.
8. Murray M, de Vries C, Wong I. A drug utilisation study of antidepressantts in children and adolescents using general practice research database. Arch Dis Child 2005; 89: 1098-102.
9. Rønning M, Blix H, Harr L et al. Legemiddelforbruket i Norge. Oslo: Nasjonalt folkehelseinstitutt, 2004.
10. Øydvin K, Rønning M, Sakshaug S et al. Legemiddelforbruket i Norge. Oslo: Norsk Medisinaldepot, 1997.
11. Meijer W, Heerdink E, Leufkens H et al. Incidence and determinants of long term use of antidepressants. Eur J Clin Pharmacol 2004; 60: 57-61.
12. Grunebaum M, Ellis S, Li S et al. Antidepressants and suicide risk in the United States, 1985-1999. J Clin Psychiatry 2004; 65: 1456-62.
13. Martinez C, Rietbrock S, Wise L, et al. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ 2005; 330: 1-7.
14. Kringlen E, Torgersen S, Cramer V. A Norwegian psychiatric epidemiological study. Am J Psychiatry 2001; 158: 1091-8.
15. Ayuso-Mateos J, Vázquez-Barquero J, Dowrick C et al. Depressive disorder in Europe: prevalence figures from the ODIN study. Br J Psychiatry 2001; 179: 308-16.
16. Sambamoorthi U, Olfson M, Walkup J et al. Diffusion of new generation antidepressant treatment among elderly diagnosed with depression. Med Care 2003; 41: 180-94.
17. Henriksson S, Boëthius G, Håkansson J, Isacsson G. Indications for and outcome of antidepressant medication in a general populaton: a prescription database and medical record study, in Jämtland county, Sweden, 1995. Acta Psychiatr Scand 2003; 108: 427-31.
18. Sandanger I, Nygard J, Ingebrigtsen G et al. Prevalence, incidence and age of onset of psychiatric disorders in Norway. Soc Psychiatry Psychiatr Epidemiol 1999; 34: 570-9.
19. Pathiyal A, Hylan T, Quik R et al. Antidepressant use and resource utilization in the general practitioner setting in the Netherlands. Pharmacoepidemiol Drug Saf 1998; 7: 253-20.
20. Stuck A, Beers M, Steiner A et al. Inappropriate medication use in community-residing older persons. Arch Intern Med 1994; 154: 2195-200.
21. Ruths S, Straand J, Nygaard H. Psychotropic drug use in nursing homes - diagnostic indications and variations between institutions. Eur J Clin Pharmacol 2001; 57: 523-8.
22. Kairuz T, Truter I, Hugo J et al. Prescribing patterns of tricyclic and selective serotonin reuptake inhibitor antidepressants among a sample of adolescents and young adults. Pharmacoepidemiol Drug Saf 2003; 12: 379-82.
23. Committee on the safety of medicine: Overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents. London: Committee on the safety of medicine, 2003.
24. Statens legemiddelverk. Depresjon hos barn og ungdom. www.legemiddelverket.no/terapi/publisert/Depresjon-barn.htm (21.4.2005).